Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling

Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS pathogens 2014-02, Vol.10 (2), p.e1003960-e1003960
Hauptverfasser: van Gent, Michiel, Braem, Steven G E, de Jong, Annemieke, Delagic, Nezira, Peeters, Janneke G C, Boer, Ingrid G J, Moynagh, Paul N, Kremmer, Elisabeth, Wiertz, Emmanuel J, Ovaa, Huib, Griffin, Bryan D, Ressing, Maaike E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e1003960
container_issue 2
container_start_page e1003960
container_title PLoS pathogens
container_volume 10
creator van Gent, Michiel
Braem, Steven G E
de Jong, Annemieke
Delagic, Nezira
Peeters, Janneke G C
Boer, Ingrid G J
Moynagh, Paul N
Kremmer, Elisabeth
Wiertz, Emmanuel J
Ovaa, Huib
Griffin, Bryan D
Ressing, Maaike E
description Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.
doi_str_mv 10.1371/journal.ppat.1003960
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1507832924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A364854202</galeid><doaj_id>oai_doaj_org_article_7a3f141db34946119f8c45c72780d9fc</doaj_id><sourcerecordid>A364854202</sourcerecordid><originalsourceid>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</originalsourceid><addsrcrecordid>eNqVks1u1DAUhSMEoqXwBggssYFFBjt2EmdTqa1aGGkEiJ-15XGuMx4SO9hOgWfgpXE606ojsUGRlej6OyfX1yfLnhO8ILQmb7du8lb2i3GUcUEwpk2FH2THpCxpXtOaPbz3fZQ9CWGLMSOUVI-zo4KVvCIVO87-XI4hgrH5ufQeXRs_BdRL3wGK0E0D2IhG72YCnX9aXRGknI3erKcIAUWHjLUyAjLDMFlAcC2DcRbFjXdTt0m7EbwGD1YB-mniJkn6Pu_Nd0AeFIzReRRMl85hbPc0e6RlH-DZ_n2Sfbu6_HrxPl99fLe8OFvlqsY05o3GknGGGciqUYXkrAXG9RrXUPK5RHhZ6LTWJVScEdUSwBWRbVNorFpMT7KXO9-xd0Hs5xgEKXHNadEULBHLHdE6uRWjN4P0v4WTRtwUnO-E9NGoHkQtqSaMtGvKGlYR0miuWKnqoua4bbRKXqf7v03rAVqVRuplf2B6uGPNRnTuWtCG4rKZ2329N_DuxwQhisEEBX0vLbjppm9GqqJic9-vdmgnU2vGapcc1YyLM1oxXrICF4la_INKTwuDSfcL2qT6geDNgWDOAPyKnZxCEMsvn_-D_XDIsh2rvAvBg76bCsFiDvnt5Yg55GIf8iR7cX-id6LbVNO_McL6uQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504162644</pqid></control><display><type>article</type><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>PubMed Central</source><creator>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E</creator><contributor>Coscoy, Laurent</contributor><creatorcontrib>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E ; Coscoy, Laurent</creatorcontrib><description>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1003960</identifier><identifier>PMID: 24586164</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Biology ; Enzyme-Linked Immunosorbent Assay ; Epstein-Barr virus ; Epstein-Barr Virus Infections - immunology ; Epstein-Barr Virus Infections - metabolism ; Flow Cytometry ; Fluorescent Antibody Technique ; Herpesvirus 4, Human ; Herpesviruses ; Host-bacteria relationships ; Humans ; Immune Evasion - immunology ; Immune response ; Immune system ; Immunity, Innate ; Immunoblotting ; Infections ; Medical research ; Microbiological research ; Physiological aspects ; Signal Transduction - immunology ; Toll-like receptors ; Toll-Like Receptors - immunology ; Toll-Like Receptors - metabolism ; Transfection ; Viral infections ; Viral Regulatory and Accessory Proteins - immunology ; Viral Regulatory and Accessory Proteins - metabolism</subject><ispartof>PLoS pathogens, 2014-02, Vol.10 (2), p.e1003960-e1003960</ispartof><rights>COPYRIGHT 2014 Public Library of Science</rights><rights>2014 van Gent et al 2014 van Gent et al</rights><rights>2014 van Gent et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: van Gent M, Braem SGE, de Jong A, Delagic N, Peeters JGC, et al. (2014) Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling. PLoS Pathog 10(2): e1003960. doi:10.1371/journal.ppat.1003960</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</citedby><cites>FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930590/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,2106,2932,23875,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24586164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Coscoy, Laurent</contributor><creatorcontrib>van Gent, Michiel</creatorcontrib><creatorcontrib>Braem, Steven G E</creatorcontrib><creatorcontrib>de Jong, Annemieke</creatorcontrib><creatorcontrib>Delagic, Nezira</creatorcontrib><creatorcontrib>Peeters, Janneke G C</creatorcontrib><creatorcontrib>Boer, Ingrid G J</creatorcontrib><creatorcontrib>Moynagh, Paul N</creatorcontrib><creatorcontrib>Kremmer, Elisabeth</creatorcontrib><creatorcontrib>Wiertz, Emmanuel J</creatorcontrib><creatorcontrib>Ovaa, Huib</creatorcontrib><creatorcontrib>Griffin, Bryan D</creatorcontrib><creatorcontrib>Ressing, Maaike E</creatorcontrib><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</description><subject>Biology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Epstein-Barr virus</subject><subject>Epstein-Barr Virus Infections - immunology</subject><subject>Epstein-Barr Virus Infections - metabolism</subject><subject>Flow Cytometry</subject><subject>Fluorescent Antibody Technique</subject><subject>Herpesvirus 4, Human</subject><subject>Herpesviruses</subject><subject>Host-bacteria relationships</subject><subject>Humans</subject><subject>Immune Evasion - immunology</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Immunity, Innate</subject><subject>Immunoblotting</subject><subject>Infections</subject><subject>Medical research</subject><subject>Microbiological research</subject><subject>Physiological aspects</subject><subject>Signal Transduction - immunology</subject><subject>Toll-like receptors</subject><subject>Toll-Like Receptors - immunology</subject><subject>Toll-Like Receptors - metabolism</subject><subject>Transfection</subject><subject>Viral infections</subject><subject>Viral Regulatory and Accessory Proteins - immunology</subject><subject>Viral Regulatory and Accessory Proteins - metabolism</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNqVks1u1DAUhSMEoqXwBggssYFFBjt2EmdTqa1aGGkEiJ-15XGuMx4SO9hOgWfgpXE606ojsUGRlej6OyfX1yfLnhO8ILQmb7du8lb2i3GUcUEwpk2FH2THpCxpXtOaPbz3fZQ9CWGLMSOUVI-zo4KVvCIVO87-XI4hgrH5ufQeXRs_BdRL3wGK0E0D2IhG72YCnX9aXRGknI3erKcIAUWHjLUyAjLDMFlAcC2DcRbFjXdTt0m7EbwGD1YB-mniJkn6Pu_Nd0AeFIzReRRMl85hbPc0e6RlH-DZ_n2Sfbu6_HrxPl99fLe8OFvlqsY05o3GknGGGciqUYXkrAXG9RrXUPK5RHhZ6LTWJVScEdUSwBWRbVNorFpMT7KXO9-xd0Hs5xgEKXHNadEULBHLHdE6uRWjN4P0v4WTRtwUnO-E9NGoHkQtqSaMtGvKGlYR0miuWKnqoua4bbRKXqf7v03rAVqVRuplf2B6uGPNRnTuWtCG4rKZ2329N_DuxwQhisEEBX0vLbjppm9GqqJic9-vdmgnU2vGapcc1YyLM1oxXrICF4la_INKTwuDSfcL2qT6geDNgWDOAPyKnZxCEMsvn_-D_XDIsh2rvAvBg76bCsFiDvnt5Yg55GIf8iR7cX-id6LbVNO_McL6uQ</recordid><startdate>20140201</startdate><enddate>20140201</enddate><creator>van Gent, Michiel</creator><creator>Braem, Steven G E</creator><creator>de Jong, Annemieke</creator><creator>Delagic, Nezira</creator><creator>Peeters, Janneke G C</creator><creator>Boer, Ingrid G J</creator><creator>Moynagh, Paul N</creator><creator>Kremmer, Elisabeth</creator><creator>Wiertz, Emmanuel J</creator><creator>Ovaa, Huib</creator><creator>Griffin, Bryan D</creator><creator>Ressing, Maaike E</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140201</creationdate><title>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</title><author>van Gent, Michiel ; Braem, Steven G E ; de Jong, Annemieke ; Delagic, Nezira ; Peeters, Janneke G C ; Boer, Ingrid G J ; Moynagh, Paul N ; Kremmer, Elisabeth ; Wiertz, Emmanuel J ; Ovaa, Huib ; Griffin, Bryan D ; Ressing, Maaike E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c703t-9f0a48404ea69c2a84de48fb07e58a69c1852f852b5e6841cd1e061ad92f0cd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Epstein-Barr virus</topic><topic>Epstein-Barr Virus Infections - immunology</topic><topic>Epstein-Barr Virus Infections - metabolism</topic><topic>Flow Cytometry</topic><topic>Fluorescent Antibody Technique</topic><topic>Herpesvirus 4, Human</topic><topic>Herpesviruses</topic><topic>Host-bacteria relationships</topic><topic>Humans</topic><topic>Immune Evasion - immunology</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Immunity, Innate</topic><topic>Immunoblotting</topic><topic>Infections</topic><topic>Medical research</topic><topic>Microbiological research</topic><topic>Physiological aspects</topic><topic>Signal Transduction - immunology</topic><topic>Toll-like receptors</topic><topic>Toll-Like Receptors - immunology</topic><topic>Toll-Like Receptors - metabolism</topic><topic>Transfection</topic><topic>Viral infections</topic><topic>Viral Regulatory and Accessory Proteins - immunology</topic><topic>Viral Regulatory and Accessory Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Gent, Michiel</creatorcontrib><creatorcontrib>Braem, Steven G E</creatorcontrib><creatorcontrib>de Jong, Annemieke</creatorcontrib><creatorcontrib>Delagic, Nezira</creatorcontrib><creatorcontrib>Peeters, Janneke G C</creatorcontrib><creatorcontrib>Boer, Ingrid G J</creatorcontrib><creatorcontrib>Moynagh, Paul N</creatorcontrib><creatorcontrib>Kremmer, Elisabeth</creatorcontrib><creatorcontrib>Wiertz, Emmanuel J</creatorcontrib><creatorcontrib>Ovaa, Huib</creatorcontrib><creatorcontrib>Griffin, Bryan D</creatorcontrib><creatorcontrib>Ressing, Maaike E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Gent, Michiel</au><au>Braem, Steven G E</au><au>de Jong, Annemieke</au><au>Delagic, Nezira</au><au>Peeters, Janneke G C</au><au>Boer, Ingrid G J</au><au>Moynagh, Paul N</au><au>Kremmer, Elisabeth</au><au>Wiertz, Emmanuel J</au><au>Ovaa, Huib</au><au>Griffin, Bryan D</au><au>Ressing, Maaike E</au><au>Coscoy, Laurent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2014-02-01</date><risdate>2014</risdate><volume>10</volume><issue>2</issue><spage>e1003960</spage><epage>e1003960</epage><pages>e1003960-e1003960</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Viral infection triggers an early host response through activation of pattern recognition receptors, including Toll-like receptors (TLR). TLR signaling cascades induce production of type I interferons and proinflammatory cytokines involved in establishing an anti-viral state as well as in orchestrating ensuing adaptive immunity. To allow infection, replication, and persistence, (herpes)viruses employ ingenious strategies to evade host immunity. The human gamma-herpesvirus Epstein-Barr virus (EBV) is a large, enveloped DNA virus persistently carried by more than 90% of adults worldwide. It is the causative agent of infectious mononucleosis and is associated with several malignant tumors. EBV activates TLRs, including TLR2, TLR3, and TLR9. Interestingly, both the expression of and signaling by TLRs is attenuated during productive EBV infection. Ubiquitination plays an important role in regulating TLR signaling and is controlled by ubiquitin ligases and deubiquitinases (DUBs). The EBV genome encodes three proteins reported to exert in vitro deubiquitinase activity. Using active site-directed probes, we show that one of these putative DUBs, the conserved herpesvirus large tegument protein BPLF1, acts as a functional DUB in EBV-producing B cells. The BPLF1 enzyme is expressed during the late phase of lytic EBV infection and is incorporated into viral particles. The N-terminal part of the large BPLF1 protein contains the catalytic site for DUB activity and suppresses TLR-mediated activation of NF-κB at, or downstream of, the TRAF6 signaling intermediate. A catalytically inactive mutant of this EBV protein did not reduce NF-κB activation, indicating that DUB activity is essential for attenuating TLR signal transduction. Our combined results show that EBV employs deubiquitination of signaling intermediates in the TLR cascade as a mechanism to counteract innate anti-viral immunity of infected hosts.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24586164</pmid><doi>10.1371/journal.ppat.1003960</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1553-7374
ispartof PLoS pathogens, 2014-02, Vol.10 (2), p.e1003960-e1003960
issn 1553-7374
1553-7366
1553-7374
language eng
recordid cdi_plos_journals_1507832924
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; Public Library of Science (PLoS) Journals Open Access; PubMed Central
subjects Biology
Enzyme-Linked Immunosorbent Assay
Epstein-Barr virus
Epstein-Barr Virus Infections - immunology
Epstein-Barr Virus Infections - metabolism
Flow Cytometry
Fluorescent Antibody Technique
Herpesvirus 4, Human
Herpesviruses
Host-bacteria relationships
Humans
Immune Evasion - immunology
Immune response
Immune system
Immunity, Innate
Immunoblotting
Infections
Medical research
Microbiological research
Physiological aspects
Signal Transduction - immunology
Toll-like receptors
Toll-Like Receptors - immunology
Toll-Like Receptors - metabolism
Transfection
Viral infections
Viral Regulatory and Accessory Proteins - immunology
Viral Regulatory and Accessory Proteins - metabolism
title Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T20%3A34%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epstein-Barr%20virus%20large%20tegument%20protein%20BPLF1%20contributes%20to%20innate%20immune%20evasion%20through%20interference%20with%20toll-like%20receptor%20signaling&rft.jtitle=PLoS%20pathogens&rft.au=van%20Gent,%20Michiel&rft.date=2014-02-01&rft.volume=10&rft.issue=2&rft.spage=e1003960&rft.epage=e1003960&rft.pages=e1003960-e1003960&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1003960&rft_dat=%3Cgale_plos_%3EA364854202%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504162644&rft_id=info:pmid/24586164&rft_galeid=A364854202&rft_doaj_id=oai_doaj_org_article_7a3f141db34946119f8c45c72780d9fc&rfr_iscdi=true